Home
Sun Pharmaceuticals Industries Ltd Quarterly Result

Sun Pharmaceuticals Industries Ltd
NSE: SUNPHARMA
Net Profit - Last Quarter
Sun Pharmaceuticals Industries Ltd Quarterly Results Key Highlights
- The revenue of Sun Pharmaceuticals Industries Ltd for the Dec '24 is ₹ 14141 crore as compare to the Sep '24 revenue of ₹ 13645 crore.
- This represent the growth of 3.63%a1# The ebitda of Sun Pharmaceuticals Industries Ltd for the Dec '24 is ₹ 4158 crore as compare to the Sep '24 ebitda of ₹ 4292 crore.
- This represent the decline of -3.13%a1# The net profit of Sun Pharmaceuticals Industries Ltd for the Dec '24 is ₹ 2917 crore as compare to the Sep '24 net profit of ₹ 3030 crore.
- This represent the decline of -3.73%a1#.
Sun Pharmaceuticals Industries Ltd Quarterly Results Analysis
Market Price of Sun Pharmaceuticals Industries Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 1643.05 |
20 Feb 2025 | 1669.7 |
19 Feb 2025 | 1678 |
18 Feb 2025 | 1701.55 |
17 Feb 2025 | 1713.4 |
14 Feb 2025 | 1704.65 |
13 Feb 2025 | 1746.5 |
12 Feb 2025 | 1693.65 |
11 Feb 2025 | 1699.75 |
10 Feb 2025 | 1732.55 |
Historical Revenue of Sun Pharmaceuticals Industries Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Sun Pharmaceuticals Industries Ltd
Historical EBITDA of Sun Pharmaceuticals Industries Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Sun Pharmaceuticals Industries Ltd
Historical Net Profit of Sun Pharmaceuticals Industries Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Sun Pharmaceuticals Industries Ltd
Sun Pharmaceuticals Industries Ltd News Hub
Sun Pharmaceuticals Industries Ltd spurts 0.31%, up for fifth straight session
Sun Pharmaceuticals Industries Ltd gained for a fifth straight session today. The stock is quoting a
Read more
20 Aug 24
Sun Pharmaceutical to invest USD 15 mn in Pharmazz Inc.
Sun Pharmaceutical Industries has entered into an agreement with Pharmazz Inc. Delaware US, pursuant
Read more
14 Aug 24
Sun Pharma Q1 PAT climbs 40% YoY to Rs 2,835 cr
Profit before tax was at Rs 3,423.5 crore in Q1 FY25, registering a growth of 37.98% on YoY basis. D
Read more
01 Aug 24
Sun Pharmaceuticals Industries consolidated net profit rises 40.20% in the June 2024 quarter
Net profit of Sun Pharmaceuticals Industries rose 40.20% to Rs 2835.62 crore in the quarter ended Ju
Read more
01 Aug 24
Document
Concalls
July 2024
PPTMay 2024
TranscriptMar 2024
PPTFeb 2024
TranscriptJan 2024
PPTNov 2023
TranscriptSep 2023
PPTMay 2023
TranscriptApr 2023
PPTNov 2022
TranscriptSep 2022
PPTAug 2022
TranscriptJune 2022
TranscriptMar 2022
PPTFeb 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptJune 2021
TranscriptJan 2021
TranscriptJuly 2024
PPTMay 2024
TranscriptMar 2024
PPTFeb 2024
TranscriptJan 2024
PPTNov 2023
TranscriptSep 2023
PPTMay 2023
TranscriptApr 2023
PPTNov 2022
TranscriptSep 2022
PPTAug 2022
TranscriptJune 2022
TranscriptMar 2022
PPTFeb 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptJune 2021
TranscriptJan 2021
Transcript